Wikidata

(Q63319051)

English

Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

clinical trial

In more languages

Statements

title
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors (English)
0 references
medical condition
insulinoma
0 references
gastrinoma
0 references
glucagonoma
0 references
somatostatinoma
0 references
start time
December 2012
0 references
end time
January 2019
0 references
number of participants
20
0 references
research intervention
bevacizumab
0 references
capecitabine
0 references
temozolomide
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63319051&oldid=1857122181"